echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Click chemistry platform is expected to improve the efficacy and safety of various anti-cancer therapies

    Click chemistry platform is expected to improve the efficacy and safety of various anti-cancer therapies

    • Last Update: 2021-12-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On November 11, 2021, Shasqi announced the completion of a US$50 million Series B financing


    Most cancer therapies usually only 1%-2% of the drug delivery can accurately target the tumor


    ▲The mechanism of the CAPAC technology platform (picture source: Shasqi's official website)

    In preclinical models, this novel, highly targeted delivery technology can increase the active drug at the tumor site by more than 25 times, resulting in a high-level, sustainable response with fewer side effects than current methods


    Shasqi's pilot project SQ3370, the interim data of the Phase 1 clinical trial for the treatment of advanced sarcoma and other solid tumors, was announced earlier this year, demonstrating the therapy’s encouraging safety profile and early signs of clinical activity


    Reference materials:

    [1] Shasqi Raises $50 Million to Expand Click Chemistry Platform Beyond Injectable Tumors and Accelerate Lead Clinical Program.


    (The original text has been deleted)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.